Cytokind Inc
CAGE Code: 8SF56
NCAGE Code: 8SF56
Status: Active
Type: Commercial Supplier
Summary
Cytokind Inc is an Active Commercial Supplier with the Cage Code 8SF56.
Address
103 Front St
Exeter NH 03833-2603
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Cfs Logistics, Inc Minuteman Tool Repair Dutch Ophthalmic, Usa, Inc. New England Air Supply And Service Nwn Acquisition Holding Company Llc Friends Inc Eh Turf Supply, Inc. New Hampshire Amateur Softball Assn Techedsoft Llc Power Resources Inc Horton Seafood Creative Development And Management Mar-Val Industries Inc White Bite Inc Msp Tool Co Inc M S P Tool Co Inc Eastern Tile And Rugs Bug Me Pest Control Louises Sport Shop Inc Arjay True Value
Frequently Asked Questions (FAQ) for CAGE 8SF56
- What is CAGE Code 8SF56?
- 8SF56 is the unique identifier used by NATO Organizations to reference the physical entity known as Cytokind Inc located at 103 Front St, Exeter NH 03833-2603, United States.
- Who is CAGE Code 8SF56?
- 8SF56 refers to Cytokind Inc located at 103 Front St, Exeter NH 03833-2603, United States.
- Where is CAGE Code 8SF56 Located?
- CAGE Code 8SF56 is located in Exeter, NH, USA.
Contracting History for CAGE 8SF56 Most Recent 25 Records
- 75A50122C00064
- Cytokind: The Overall Objective Of This Contract Is To Provide Clinical Validation For The Treatment Of Covid With Nb-Uvb Therapy. A Submission To The Fda For A New Indication Will Be Made.
- 14 Oct 2022
- Cytokind: The Overall Objective Of This Contract Is To Provide Clinical Validation For The Treatment Of Covid With Nb-Uvb Therapy. A Submission To The Fda For A New Indication Will Be Made.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,000.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00064
- Cytokind: The Overall Objective Of This Contract Is To Provide Clinical Validation For The Treatment Of Covid With Nb-Uvb Therapy. A Submission To The Fda For A New Indication Will Be Made.
- 15 Sep 2022
- Cytokind: The Overall Objective Of This Contract Is To Provide Clinical Validation For The Treatment Of Covid With Nb-Uvb Therapy. A Submission To The Fda For A New Indication Will Be Made.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,000.00
- Department Of Health And Human Services (Hhs)